Deep Infiltrating Endometriosis : Laparoscopic Nerve-sparing Surgery and Use of Neutral Argon Plasma

NCT06207448 | Completed

• 1 other identifier: 8501
• Study Type: observational
• Target: 1
• Locations: 1 country
• Sites: 1

Brief Summary

Medical treatment of endometriosis has a suspensive and sometimes incomplete effect on the symptoms, making surgical treatment necessary. The aim of surgical treatment of deep endometriosis is to restore normal anatomy and functional integrity. Resection of deep endometriosis lesions is recommended to relieve pain, gynecological and digestive symptoms, but rarely urinary disorders. Nerve-sparing surgery, when feasible, reduces post-operative dysuria by sparing the lower hypogastric plexus. The major limitations of these surgical procedures are the experience of the surgeon and the extent of the disease. Acquiring the surgical techniques and skills necessary to carry out these types of procedures is essential to providing optimal patient care.

Conditions

Endometriosis Ovary

Keywords

Endometriosis Ovary; Laparoscopic Surgery; Laparoscopic Surgical Procedure; Schwanoma

Outcome Measures

Primary Outcomes (1)

• To retrospectively describe the minimally invasive management of deep pelvic endometriosis using nerve-sparing surgery and the use of neutral argon plasma for extensive endometriotic lesions by laparoscopy

  up to 2 months

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult woman (≥18 years old) who benefited from treatment by nerve-sparing surgery and the use of neutral argon plasma in the context of symptomatic deep pelvic endometriosis at the Strasbourg University Hospital during 2021

You may qualify if:

• Adult woman (≥18 years old)
• Patient who benefited from treatment by nerve-sparing surgery and the use of neutral argon plasma in the context of symptomatic deep pelvic endometriosis at the Strasbourg University Hospital during 2021
• Patient who did not express, after information, the reuse of her data for the purposes of this research.

You may not qualify if:

• Patient who expressed her opposition to participating in the study
• Patient under legal protection, under guardianship or under curatorship

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de Gynécologie Obstétrique - CHU de Strasbourg - France

Strasbourg, 67091, France

Location

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 11, 2023
• First Posted: January 17, 2024
• Study Start: April 1, 2022
• Primary Completion: June 1, 2022
• Study Completion: June 6, 2022
• Last Updated: March 13, 2024

Record last verified: 2023-12

Locations

FR (1)